Iconix Biosciences

Varying endpoints in studies of drugs to treat pain and inflammation following eye surgery may be guided toward an officially suggested harmonization, following the Feb. 27 meeting of FDA's Dermatolog

XOMA (US) has appointed James Neal vice-president of business development. He was most recently acting chief executive officer at Entelos, which was acquired Iconix Biosciences, a privately held compa

Drug developers can now tap into an array of new preclinical technologies including some that give them the ability to interrogate compounds in a broad biological context—a systems biology approach. T

SimuGen Ltd. Innovative predictive liver toxicity testing 2 Oakington Business Park Cambridge, CB4 5DQ, UK Phone: +44 (0)870 220 5910 Fax: +44 (0)870 220 5910 Web Site: www.simugen.co.uk Contact: Quin